Novel Vilazodone–Tacrine Hybrids as Potential Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease Accompanied with Depression: Design, Synthesis, and Biological Evaluation-Reference-Cited by-同舟云学术

Novel Vilazodone–Tacrine Hybrids as Potential Multitarget-Directed Ligands for the Treatment of Alzheimer’s Disease Accompanied with Depression: Design, Synthesis, and Biological Evaluation

Published:2017-09-19 Issue:12 Volume:8 Page:2708-2721
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Li Xiaokang¹,Wang Huan²³,Xu Yixiang¹,Liu Wenwen¹,Gong Qi²,Wang Wei²,Qiu Xiaoxia¹,Zhu Jin¹^ORCID,Mao Fei¹,Zhang Haiyan²,Li Jian¹^ORCID

Affiliation:

1. Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology, 130 Mei Long Road, Shanghai 200237, China

2. CAS Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China

3. University of Chinese Academy of Science, No. 19A Yuquan Road, Beijing 100049, China

Funder

Ministry of Education of the People's Republic of China

Science and Technology Commission of Shanghai Municipality

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.7b00259

Reference60 articles.